Literature DB >> 1787808

Protocol for the use of vitamin C in the treatment of cancer.

E Cameron1.   

Abstract

A protocol for the use of vitamin C in the treatment of cancer, developed over a number of years in Vale of Leven Hospital, Scotland, is presented. Clinical experience has shown this protocol to be both safe and efficient. It need not be followed 'to the letter', but provides general guidance to physicians unfamiliar with this therapeutic approach. It recommends that all cancer patients treated in this fashion be given an initial course of intravenous ascorbate followed by a maintenance oral dose to be continued indefinitely thereafter. The importance of continuous as opposed to intermittent administration is emphasized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1787808     DOI: 10.1016/0306-9877(91)90128-l

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

Review 1.  Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

2.  Intravenously administered vitamin C as cancer therapy: three cases.

Authors:  Sebastian J Padayatty; Hugh D Riordan; Stephen M Hewitt; Arie Katz; L John Hoffer; Mark Levine
Journal:  CMAJ       Date:  2006-03-28       Impact factor: 8.262

Review 3.  Critical reappraisal of vitamins and trace minerals in nutritional support of cancer patients.

Authors:  H B Stähelin
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

4.  Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases.

Authors:  Yuen Chuen Fong Raymond; Chong Sze Ling Glenda; Lim Kah Meng
Journal:  Integr Cancer Ther       Date:  2015-12-17       Impact factor: 3.279

Review 5.  Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our Knowledge.

Authors:  Anitra C Carr; John Cook
Journal:  Front Physiol       Date:  2018-08-23       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.